Primary peritoneal cancer in pregnancy: case report and review of the literature

Introduction: As this is the second only published report of primary peritoneal cancer (PPC) in pregnancy, it aims to bring awareness and reviews the current information of this exceptionally rare condition. Case Report: The case report outlines the clinical presentation of a 31-year-old pregnant woman and how she was diagnosed with the condition. Discussion: PPC can be difficult to diagnose with similar characteristics to ovarian cancer. From studying the literature, this paper addresses the histological and immunohistochemical distinguishing features. It also addresses some of the issues with diagnosing cancer in pregnancy or for women in their reproductive years. Conclusion: As this condition is so rare in young women, this overview is a useful addition to the medical literature.

Chemotherapy in pregnancy; Neoplasia in pregnancy; Serous carcinoma; Ovarian cancer; Primary peritoneal cancer.

[1] Pavlidis N.: “Coexistence of pregnancy and malignancy”. Oncologist, 2002, 7, 279.

[2] Morice P., Uzan C., Gouy S., Verschraegen C., Haie-Meder C.: “Gynaecological cancers in pregnancy”. Lancet, 2012, 379, 558.

[3] Shameen M., Akhtar J., Baneen U., Bhargava R., Ahmed Z., Sharma P., et al.: “Primary peritoneal adenocarcinoma causes pleural effusions”. N. Am. J. Med. Sci., 2010, 2, 281.

[4] Iavazzo C., Vorgias G., Katsoulis M., Kalinoglou N., Dertimas V., Akrivos T.: “Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics”. Arch. Gynaecol. Obstet., 2008, 278, 53.

[5] Tsai H., Su C-F., Kok V., Ho W.: “Primary peritoneal cancer in pregnancy with multiple metastases: A case report”. Taipei City Med J., 2013, 10, 58.

[6] Eltabbakh G.: “Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer”. Obstet. Gynaecol., 1998, 91, 254.

[7] Goodman M., Shvetsov Y.: “Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact?” Int. J. Cancer, 2009, 124, 2231.

[8] Grant D., Moorman P., Akushevich L., Palmieri R., Bentley R., Schildkraut J.: “Primary peritoneal and ovarian cancers: an epidemiological comparative analysis”. Cancer Causes Control, 2010, 21, 991.

[9] Young R.: “From krunkenberg to today: the ever present problems posed by metastatic tumors in the ovary”. Adv. Anat. Pathol., 2006, 13, 205.

[10] Bloss J., Liao S., Buller R., Manetta A., Berman M., McMeekin S., et al.: “Extraovarian peritoneal serous papillary carcinoma: a casecontrol retrospective comparison to papillary adenocarcinoma of the ovary”. Gynecol. Oncol., 1993, 50, 347.

[11] Steinhagen P., Sehouli J.: “The involvement of retroperitoneal lymph nodes in primary serous-papillary peritoneal carcinoma. A systematic review of the literature”. Anticancer Res., 2011, 31, 1387.

[12] Dubeau L.: “The cell of origin of ovarian epithelial tumors”. Lancet Oncol., 2008, 9, 1191.

[13] Choi C.H., Kim T.J., Kim W.Y., Ahn G.H., Lee J.W., Kim B.G., et al.: “Papillary serous carcinoma in ovaries of normal size: a clinicopathologic study of 20 cases and comparison with extra ovarian peritoneal papillary serous carcinoma”. Gynaecol. Oncol., 2007, 105, 762.

[14] Von Riedenauer W.B., Janjua S.A., Kwon D.S., Zhang Z., Velanovich V.: “Immunohistochemical identification of primary peritoneal serous cystadenocarcinoma mimicking advanced colorectal carcinoma: a case report”. J. Med. Case Reports, 2007, 1, 150.

[15] Chen L.M., Yamada S.D., Fu Y.S., Baldwin R.L., Karlan B.Y.: “Molecular similarities between primary peritoneal and primary ovarian carcinomas”. Int. J. Gynecol. Cancer, 2003, 13, 749.

[16] Barnetson R.J., Burnett R.A., Downie I., Harper C.M., Roberts F.: “Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful”. Am. J. Clin. Pathol., 2006, 125, 67.

[17] Hou T., Liang D., Chen X., Zhang Y.: “Primary peritoneal serous carcinoma: a clinicopathological and immunohistochemical study of six cases”. Int. J. Clin. Exp. Pathol., 2012, 5, 762.

[18] Menczer J., Chetrit A., Barda G., Lubin F., Fishler Y., Altaras M., et al.: “Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women”. Gynecol. Oncol., 2003, 88, 58.

[19] Finch A., Beiner M., Lubinski J., Lynch H.T., Moller P., Rosen B., et al.: “Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation”. JAMA, 2006, 296, 185.

[20] Cathro H., Stoler M.H.: “Expression of cytokeratins 7 and 20 in ovarian neoplasia”. Am. J. Clin. Pathol., 2002, 117, 944

[21] Piver M.S., Eltabbakh G.H.. Hempling R.E., Recio F.O., Blumenson L.E.: “Two sequential studies for primary peritoneal carcinoma: Induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin”. Gynecol. Oncol., 1997, 67, 141.

[22] Dubernaud G., Morice P., Rey A., Camatte S., Fourchotte V., Thoury A., et al.: “Prognosis of stage III or IV primary peritoneal serous papillary carcinoma”. Eur. J. Surg. Oncol., 2004, 30, 976.

[23] Pentheroudakis G., Pavlidis N.: “Serous papillary peritoneal carcinoma: Unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review”. Crit Rev Oncol Hematol., 2010, 75, 27.

[24] Costeloe K., Hennessy E., Haider S., Stacey F., Marlow N., Draper E.: “Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies)”. BMJ, 2012, 345, e7976.

[25] Platt M.J.: “Outcomes in preterm infants”. Public Health, 2014, 128, 399.

[26] Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes, Behrman R.E., Butler A.S., (eds). Preterm birth: causes, consequences, and prevention. Washington (DC): National Academies Press (US), 2007. Available at: http://www.ncbi.nlm.nih.gov/books/NBK11362/

[27] “Preemie outcomes by gestational age (no date). Preemie help [Online]”. Available at: http://preemiehelp.com/about-preemies/preemiefacts- a-figures/preemie-outcomes/outcomes-by-gestational-age#Pree mie%20outcomes%20-%2033%20to%2036%20weeks%20gestational% 20age

[28] Banz C., Von Otte S., Noack F., Diedrich K., Hornung D.: “Primary peritoneal carcinoma in a young woman with suspected endometriosis”. Fertil. Steril., 2009, 92, 390.e5.